Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

Similar articles for PubMed (Select 19671446)

1.

Toxoplasma gondii inhibits R5 HIV-1 replication in human lymphoid tissues ex vivo.

Sassi A, Brichacek B, Hieny S, Yarovinsky F, Golding H, Grivel JC, Sher A, Margolis L.

Microbes Infect. 2009 Dec;11(14-15):1106-13. doi: 10.1016/j.micinf.2009.08.004. Epub 2009 Aug 9.

PMID:
19671446
2.

Viral interactions in human lymphoid tissue: Human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation.

Lisco A, Grivel JC, Biancotto A, Vanpouille C, Origgi F, Malnati MS, Schols D, Lusso P, Margolis LB.

J Virol. 2007 Jan;81(2):708-17. Epub 2006 Oct 25.

3.

HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1.

Grivel JC, Elliott J, Lisco A, Biancotto A, Condack C, Shattock RJ, McGowan I, Margolis L, Anton P.

AIDS. 2007 Jun 19;21(10):1263-72.

PMID:
17545702
4.

Interactions between human immunodeficiency virus type 1 and vaccinia virus in human lymphoid tissue ex vivo.

Vanpouille C, Biancotto A, Lisco A, Brichacek B.

J Virol. 2007 Nov;81(22):12458-64. Epub 2007 Sep 5.

5.

Inhibition of HIV-1 infection by a CCR5-binding cyclophilin from Toxoplasma gondii.

Golding H, Aliberti J, King LR, Manischewitz J, Andersen J, Valenzuela J, Landau NR, Sher A.

Blood. 2003 Nov 1;102(9):3280-6. Epub 2003 Jul 10.

6.

Inhibition of HIV-1 replication in human lymphoid tissues ex vivo by measles virus.

Grivel JC, García M, Moss WJ, Margolis LB.

J Infect Dis. 2005 Jul 1;192(1):71-8. Epub 2005 May 31.

7.

CCR5 N-terminal region plays a critical role in HIV-1 inhibition by Toxoplasma gondii-derived cyclophilin-18.

Golding H, Khurana S, Yarovinsky F, King LR, Abdoulaeva G, Antonsson L, Owman C, Platt EJ, Kabat D, Andersen JF, Sher A.

J Biol Chem. 2005 Aug 19;280(33):29570-7. Epub 2005 Jun 23.

8.

R5 variants of human immunodeficiency virus type 1 preferentially infect CD62L- CD4+ T cells and are potentially resistant to nucleoside reverse transcriptase inhibitors.

Gondois-Rey F, Biancotto A, Fernandez MA, Bettendroffer L, Blazkova J, Trejbalova K, Pion M, Hirsch I.

J Virol. 2006 Jan;80(2):854-65.

9.

Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue.

Karlsson I, Grivel JC, Chen SS, Karlsson A, Albert J, Fenyö EM, Margolis LB.

J Virol. 2005 Sep;79(17):11151-60.

10.

Effect of R77Q, R77A and R80A changes in Vpr on HIV-1 replication and CD4 T cell depletion in human lymphoid tissue ex vivo.

Rajan D, Wildum S, Rücker E, Schindler M, Kirchhoff F.

AIDS. 2006 Apr 4;20(6):831-6.

PMID:
16549966
11.

Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6.

Grivel JC, Ito Y, Fagà G, Santoro F, Shaheen F, Malnati MS, Fitzgerald W, Lusso P, Margolis L.

Nat Med. 2001 Nov;7(11):1232-5.

PMID:
11689888
12.

CXCR4-tropic HIV-1 suppresses replication of CCR5-tropic HIV-1 in human lymphoid tissue by selective induction of CC-chemokines.

Ito Y, Grivel JC, Chen S, Kiselyeva Y, Reichelderfer P, Margolis L.

J Infect Dis. 2004 Feb 1;189(3):506-14. Epub 2004 Jan 20.

14.

Structural determinants of the anti-HIV activity of a CCR5 antagonist derived from Toxoplasma gondii.

Yarovinsky F, Andersen JF, King LR, Caspar P, Aliberti J, Golding H, Sher A.

J Biol Chem. 2004 Dec 17;279(51):53635-42. Epub 2004 Oct 6.

15.

Upregulation of human cytomegalovirus by HIV type 1 in human lymphoid tissue ex vivo.

Biancotto A, Iglehart SJ, Lisco A, Vanpouille C, Grivel JC, Lurain NS, Reichelderfer PS, Margolis LB.

AIDS Res Hum Retroviruses. 2008 Mar;24(3):453-62. doi: 10.1089/aid.2007.0155.

PMID:
18327985
16.
17.

Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo.

Glushakova S, Yi Y, Grivel JC, Singh A, Schols D, De Clercq E, Collman RG, Margolis L.

J Clin Invest. 1999 Sep;104(5):R7-R11.

18.
19.

Segregation of R5 and X4 HIV-1 variants to memory T cell subsets differentially expressing CD62L in ex vivo infected human lymphoid tissue.

Gondois-Rey F, Grivel JC, Biancotto A, Pion M, Vigne R, Margolis LB, Hirsch I.

AIDS. 2002 Jun 14;16(9):1245-9.

PMID:
12045489
20.

Coreceptor choice and T cell depletion by R5, X4, and R5X4 HIV-1 variants in CCR5-deficient (CCR5delta32) and normal human lymphoid tissue.

Malkevitch N, McDermott DH, Yi Y, Grivel JC, Schols D, De Clercq E, Murphy PM, Glushakova S, Collman RG, Margolis L.

Virology. 2001 Mar 15;281(2):239-47.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk